Cencora, Inc. Enters Material Definitive Agreement

Ticker: COR · Form: 8-K · Filed: Oct 15, 2024 · CIK: 1140859

Cencora, INC. 8-K Filing Summary
FieldDetail
CompanyCencora, INC. (COR)
Form Type8-K
Filed DateOct 15, 2024
Risk Levelmedium
Pages5
Reading Time6 min
Key Dollar Amounts$100 million, $1,450 m, $250 million
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, financial-obligation

Related Tickers: ABC

TL;DR

Cencora (ABC) signed a big deal on Oct 9th, expect financial updates.

AI Summary

On October 9, 2024, Cencora, Inc. entered into a material definitive agreement related to a direct financial obligation. The company, formerly known as AmerisourceBergen Corp, is incorporated in Delaware and headquartered in Conshohocken, PA.

Why It Matters

This filing indicates a significant financial commitment or obligation for Cencora, Inc., which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new financial obligations or risks that may not be immediately apparent.

Key Players & Entities

FAQ

What type of material definitive agreement did Cencora, Inc. enter into?

The filing states that the agreement is related to a 'Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant', but the specific details of the agreement are not provided in this summary.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on October 9, 2024.

What was Cencora, Inc.'s former name?

Cencora, Inc.'s former name was AmerisourceBergen Corp.

In which state is Cencora, Inc. incorporated?

Cencora, Inc. is incorporated in Delaware.

What is Cencora, Inc.'s primary business classification?

Cencora, Inc.'s Standard Industrial Classification is 'WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]'.

Filing Stats: 1,514 words · 6 min read · ~5 pages · Grade level 12.7 · Accepted 2024-10-15 16:02:07

Key Financial Figures

Filing Documents

01. Entry into

Item 1.01. Entry into a Material Definitive Agreement. Amendment and Restatement of Revolving Credit Facility On October 9, 2024, Cencora, Inc. (the "Company") and its subsidiaries BP Pharmaceuticals Laboratories Unlimited Company, Centaur Services Limited and Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement (the "Amended and Restated Credit Agreement") to amend and restate the Amended and Restated Credit Agreement, dated as of October 6, 2023, among the Company, the borrowing subsidiaries party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent, pursuant to which the Company and such subsidiaries obtained a senior unsecured multi-currency revolving credit facility (the "Revolving Credit Facility"). The Revolving Credit Facility was amended and restated to, among other things, (i) extend the maturity date of the facility to October 9, 2029, (ii) reduce the applicable rate for the facility fees owed to each Lender, and (iii) replace the Canadian Dealer Offered Rate as the applicable reference rate with respect to loans denominated in Canadian Dollars with the Canadian Overnight Repo Rate Average ("CORRA"), and otherwise conform the facility to accommodate CORRA as the reference rate for loans denominated in Canadian Dollars. Interest on borrowings under the Revolving Credit Facility accrue at specified rates based on the Company's public debt ratings by Standard & Poor's Ratings Services, Moody's Investors Service, Inc. and Fitch, Inc., and pursuant to the Amended and Restated Credit Agreement, ranges from 80.5 basis points to 122.5 basis points over Term SOFR, Term CORRA, EURIBO Rate, and the RFR, as applicable, and 0 basis points to 22.5 basis points over the alternate base rate and Canadian prime rate, as applicable, in each case, as determined in accordance with the provisions of the Revolving Credit Facility. The Company has agreed to pay facility fees to maintain the availability under th

03. Creation of Direct Financial

Item 2.03. Creation of Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 above is hereby incorporated by reference into this Item 2.03.

01. Financial

Item 9.01. Financial (d) Exhibits. Exhibit No. Description 10.1 Amended and Restated Credit Agreement, dated as of October 9, 2024, among Cencora, Inc., the borrowing subsidiaries party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent. 10.2 Twenty-First Amendment to Amended and Restated Receivables Purchase Agreement, dated as of October 9, 2024, among Amerisource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and MUFG Bank, Ltd., as administrator 104 Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CENCORA, INC. October 15, 2024 By: /s/ James F. Cleary Name: James F. Cleary Title: Executive Vice President & Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing